Minimal monitoring of DAA therapy proven safe

A randomised controlled trial of standard versus minimal monitoring during hepatitis C treatment has confirmed that clinical outcomes, patient satisfaction and adherence are similar in both groups. The findings, from trial sites at John Hunter Hospital and Royal Darwin Hospital, support an upcoming consensus statement recommendation for minimal monitoring. Conjoint Professor Joshua Davis from John ...

Already a member?

Login to keep reading.

© 2021 the limbic